top of page

LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety Disorders

About the study

NCT Trial Number

NCT03153579

The drug being studied

LSD

noun_Drug_2240951.png
noun_Institution_118530.png

Sponsored by

University Hospital, Basel, Switzerland

noun_date_3237048.png

Trial Start Date

May 31, 2017

noun_capsule_138144.png

About the participants

Age seeking

25 Years and older

gender

All

noun_Mental Health_2683241.png

Primary condition of volunteers accepted

Anxiety

noun_square_138133.png

Accepts healthy volunteers?

No

This study will explore he efficacy of LSD in patients with anxiety with or without life-threatening diseases.

Eyes Graffiti

Locations


Switzerland
University Hospital Basel
Basel, BS, Switzerland, 4056

Contact: Matthias E Liechti, MD, MAS
+4161328 68 68
matthias.liechti@usb.ch

Contact: Patrick C Dolder
+41 61 556 54 37
patrick.dolder@usb.ch

Private Practice P.Gasser
Solothurn, SO, Switzerland, 4500

Contact: Peter Gasser, MD
+4132 622 40 20
pgasser@gmx.net

​

​

​

​

Get in contact

Find a study site convenient for you below, then email yourself the contact details and next steps

bottom of page